Article info

Download PDFPDF

Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen

Authors

  • Stefanie K. Wculek Immunobiology LaboratoryCentro Nacional de Investigaciones Cardiovasculares (CNIC) Melchor Fernández Almagro, 3 28029 Madrid Spain PubMed articlesGoogle scholar articles
  • Joaquín Amores-Iniesta Immunobiology LaboratoryCentro Nacional de Investigaciones Cardiovasculares (CNIC) Melchor Fernández Almagro, 3 28029 Madrid Spain PubMed articlesGoogle scholar articles
  • Ruth Conde-Garrosa Immunobiology LaboratoryCentro Nacional de Investigaciones Cardiovasculares (CNIC) Melchor Fernández Almagro, 3 28029 Madrid Spain PubMed articlesGoogle scholar articles
  • Sofía C. Khouili Immunobiology LaboratoryCentro Nacional de Investigaciones Cardiovasculares (CNIC) Melchor Fernández Almagro, 3 28029 Madrid Spain PubMed articlesGoogle scholar articles
  • Ignacio Melero Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA)University of Navarra, and Instituto de Investigación Sanitaria de Navarra (IdISNA) Pamplona Spain University ClinicUniversity of Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA) Pamplona Spain Centro de Investigación Biomédica en Red Cáncer (CIBERONC) Madrid Spain PubMed articlesGoogle scholar articles
  • David Sancho Immunobiology LaboratoryCentro Nacional de Investigaciones Cardiovasculares (CNIC) Melchor Fernández Almagro, 3 28029 Madrid Spain PubMed articlesGoogle scholar articles
  1. a stefanie.wculek{at}cnic.es
  2. b joaquin.amores{at}cnic.es
  3. c ruth.conde{at}cnic.es
  4. d sofia.chayeb{at}cnic.es
  5. e imelero{at}unav.es
  6. f (+34) 914531200 dsancho{at}cnic.es
View Full Text

Citation

Wculek SK, Amores-Iniesta J, Conde-Garrosa R, et al
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen

Publication history

  • Received November 22, 2018
  • Accepted March 12, 2019
  • First published April 8, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.